Email
Print
1. Cancer Pain Market - Overview
1.1 Definitions and Scope
2. Cancer Pain Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer Pain Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer Pain Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer Pain Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer Pain Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer Pain Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Cancer Pain Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Cancer Pain Market - By Type(Market Size -$Million / $Billion)
9.1 CANCER PAIN MARKET, BY DRUG TYPE
9.1.1 Opioids
9.1.1.1 Morphine
9.1.1.2 Fentanyl
9.1.2 Non-opioids
9.1.2.1 Acetaminophen
9.1.2.2 Non-Steroidal Anti-Inflammatory Drugs
9.1.3 Nerve blockers
9.2 CANCER PAIN MARKET, BY DISEASE INDICATION
9.2.1 Lung cancer
9.2.2 Colorectal cancer
9.2.3 Breast cancer
9.2.4 Prostate cancer
9.2.5 Blood cancer
10. Cancer Pain - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Cancer Pain- By Geography (Market Size -$Million / $Billion)
11.1 Cancer Pain Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer Pain- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer Pain- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer Pain - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer Pain - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer Pain Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Pain Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer Pain Market - Key Company List by Country Premium
15. Cancer Pain Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 AOXING PHARMACEUTICAL COMPANY, INC.
15.3 BIODELIVERY SCIENCES INTERNATIONAL, INC.
15.4 DAIICHI SANKYO CO., LTD.
15.5 GRNENTHAL PHARMA GmbH CO. KG
15.6 HISAMITSU PHARMACEUTICAL CO., INC.
15.7 INSYS THERAPEUTICS, INC.
15.8 MUNDIPHARMA INTERNATIONAL LIMITED
15.9 OREXO AB
15.10 PFIZER INC.
15.11 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Cancer Pain Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Cancer Pain Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer Pain Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer Pain Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer Pain Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer Pain Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer Pain Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Cancer Pain Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Cancer Pain Market - By Type(Market Size -$Million / $Billion)
9.1 CANCER PAIN MARKET, BY DRUG TYPE
9.1.1 Opioids
9.1.1.1 Morphine
9.1.1.2 Fentanyl
9.1.2 Non-opioids
9.1.2.1 Acetaminophen
9.1.2.2 Non-Steroidal Anti-Inflammatory Drugs
9.1.3 Nerve blockers
9.2 CANCER PAIN MARKET, BY DISEASE INDICATION
9.2.1 Lung cancer
9.2.2 Colorectal cancer
9.2.3 Breast cancer
9.2.4 Prostate cancer
9.2.5 Blood cancer
10. Cancer Pain - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Cancer Pain- By Geography (Market Size -$Million / $Billion)
11.1 Cancer Pain Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer Pain- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer Pain- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer Pain - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer Pain - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer Pain Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Pain Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer Pain Market - Key Company List by Country Premium
15. Cancer Pain Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 AOXING PHARMACEUTICAL COMPANY, INC.
15.3 BIODELIVERY SCIENCES INTERNATIONAL, INC.
15.4 DAIICHI SANKYO CO., LTD.
15.5 GRNENTHAL PHARMA GmbH CO. KG
15.6 HISAMITSU PHARMACEUTICAL CO., INC.
15.7 INSYS THERAPEUTICS, INC.
15.8 MUNDIPHARMA INTERNATIONAL LIMITED
15.9 OREXO AB
15.10 PFIZER INC.
15.11 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Cancer Pain Market - Appendix16.1 Abbreviations
16.2 Sources
17. Cancer Pain Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)1.1 Opioids Market 2023-2030 ($M) - Global Industry Research
1.1.1 Morphine Market 2023-2030 ($M)
1.1.2 Fentanyl Market 2023-2030 ($M)
1.2 Non-opioids Market 2023-2030 ($M) - Global Industry Research
1.2.1 Acetaminophen Market 2023-2030 ($M)
1.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
1.3 Nerve blockers Market 2023-2030 ($M) - Global Industry Research
2.Global CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
2.1 Lung cancer Market 2023-2030 ($M) - Global Industry Research
2.2 Colorectal cancer Market 2023-2030 ($M) - Global Industry Research
2.3 Breast cancer Market 2023-2030 ($M) - Global Industry Research
2.4 Prostate cancer Market 2023-2030 ($M) - Global Industry Research
2.5 Blood cancer Market 2023-2030 ($M) - Global Industry Research
3.Global CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 (Volume/Units)
3.1 Opioids Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Morphine Market 2023-2030 (Volume/Units)
3.1.2 Fentanyl Market 2023-2030 (Volume/Units)
3.2 Non-opioids Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Acetaminophen Market 2023-2030 (Volume/Units)
3.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 (Volume/Units)
3.3 Nerve blockers Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 (Volume/Units)
4.1 Lung cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Colorectal cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Breast cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Prostate cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Blood cancer Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
5.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Morphine Market 2023-2030 ($M)
5.1.2 Fentanyl Market 2023-2030 ($M)
5.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Acetaminophen Market 2023-2030 ($M)
5.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
5.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
6.North America CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
6.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
6.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
6.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
6.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
6.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
7.South America CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
7.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Morphine Market 2023-2030 ($M)
7.1.2 Fentanyl Market 2023-2030 ($M)
7.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Acetaminophen Market 2023-2030 ($M)
7.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
7.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
8.South America CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
8.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
8.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
8.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
8.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
8.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
9.Europe CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
9.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Morphine Market 2023-2030 ($M)
9.1.2 Fentanyl Market 2023-2030 ($M)
9.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Acetaminophen Market 2023-2030 ($M)
9.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
9.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
10.Europe CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
10.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
10.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
10.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
10.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
10.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
11.APAC CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
11.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Morphine Market 2023-2030 ($M)
11.1.2 Fentanyl Market 2023-2030 ($M)
11.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Acetaminophen Market 2023-2030 ($M)
11.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
11.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
12.APAC CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
12.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
12.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
12.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
12.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
12.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
13.MENA CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
13.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Morphine Market 2023-2030 ($M)
13.1.2 Fentanyl Market 2023-2030 ($M)
13.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Acetaminophen Market 2023-2030 ($M)
13.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
13.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
14.MENA CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
14.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
14.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
14.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
14.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
14.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Cancer Pain Market Revenue, 2023-2030 ($M)2.Canada Cancer Pain Market Revenue, 2023-2030 ($M)
3.Mexico Cancer Pain Market Revenue, 2023-2030 ($M)
4.Brazil Cancer Pain Market Revenue, 2023-2030 ($M)
5.Argentina Cancer Pain Market Revenue, 2023-2030 ($M)
6.Peru Cancer Pain Market Revenue, 2023-2030 ($M)
7.Colombia Cancer Pain Market Revenue, 2023-2030 ($M)
8.Chile Cancer Pain Market Revenue, 2023-2030 ($M)
9.Rest of South America Cancer Pain Market Revenue, 2023-2030 ($M)
10.UK Cancer Pain Market Revenue, 2023-2030 ($M)
11.Germany Cancer Pain Market Revenue, 2023-2030 ($M)
12.France Cancer Pain Market Revenue, 2023-2030 ($M)
13.Italy Cancer Pain Market Revenue, 2023-2030 ($M)
14.Spain Cancer Pain Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cancer Pain Market Revenue, 2023-2030 ($M)
16.China Cancer Pain Market Revenue, 2023-2030 ($M)
17.India Cancer Pain Market Revenue, 2023-2030 ($M)
18.Japan Cancer Pain Market Revenue, 2023-2030 ($M)
19.South Korea Cancer Pain Market Revenue, 2023-2030 ($M)
20.South Africa Cancer Pain Market Revenue, 2023-2030 ($M)
21.North America Cancer Pain By Application
22.South America Cancer Pain By Application
23.Europe Cancer Pain By Application
24.APAC Cancer Pain By Application
25.MENA Cancer Pain By Application
26.AOXING PHARMACEUTICAL COMPANY, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.BIODELIVERY SCIENCES INTERNATIONAL, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.DAIICHI SANKYO CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.GRNENTHAL PHARMA GmbH CO. KG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.HISAMITSU PHARMACEUTICAL CO., INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.INSYS THERAPEUTICS, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.MUNDIPHARMA INTERNATIONAL LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.OREXO AB, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.PFIZER INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.TEVA PHARMACEUTICAL INDUSTRIES LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)